A quantitative atlas of histone modification signatures from human cancer cells - Wikidata - awgldk - TriplyDB

A quantitative atlas of histone modification signatures from human cancer cells

A quantitative atlas of histone modification signatures from human cancer cells

http://www.wikidata.org/entity/Q37008808

about

Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations Plasmodium falciparum PfSET7: enzymatic characterization and cellular localization of a novel protein methyltransferase in sporozoite, liver and erythrocytic stage parasites Quantitative proteomic analysis of histone modifications ChIP-less analysis of chromatin states.Quantitative chromatin proteomics reveals a dynamic histone post-translational modification landscape that defines asexual and sexual Plasmodium falciparum parasites Accelerated chromatin biochemistry using DNA-barcoded nucleosome libraries.Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4.Chromatin Memory in the Development of Human Cancers Towards understanding methyllysine readout.Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis Multi-faceted quantitative proteomics analysis of histone H2B isoforms and their modifications.Calibrating ChIP-Seq with Nucleosomal Internal Standards to Measure Histone Modification Density Genome Wide.MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples.Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns Dot1 histone methyltransferases share a distributive mechanism but have highly diverged catalytic properties.BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones.Streamlined discovery of cross-linked chromatin complexes and associated histone modifications by mass spectrometry.H3K23me2 is a new heterochromatic mark in Caenorhabditis elegans.Histone H4 Lysine 20 (H4K20) Methylation, Expanding the Signaling Potential of the Proteome One Methyl Moiety at a Time.Analysis of histone post translational modifications in primary monocyte derived macrophages using reverse phase×reverse phase chromatography in conjunction with porous graphitic carbon stationary phase.Reader domain specificity and lysine demethylase-4 family function.Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer.Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?Metabolic regulation of histone post-translational modifications.Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic.The contribution of mass spectrometry-based proteomics to understanding epigenetics.The upstreams and downstreams of H3K79 methylation by DOT1L.Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.Citrullination/Methylation Crosstalk on Histone H3 Regulates ER-Target Gene Transcription.Epiproteomics: quantitative analysis of histone marks and codes by mass spectrometry.Identification of structural features of 2-alkylidene-1,3-dicarbonyl derivatives that induce inhibition and/or activation of histone acetyltransferases KAT3B/p300 and KAT2B/PCAF.Improved bottom-up strategy to efficiently separate hypermodified histone peptides through ultra-HPLC separation on a bench top Orbitrap instrument.Histone H3 lysine 27 acetylation is altered in colon cancer A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A).Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma

P2860

Q26781745-93B218DE-A35E-4220-91FF-6C40B3250D88 Q27973726-0CEC3E90-F4B7-46DA-B77B-5BA6FC90A154 Q30375585-8CAC9DB1-DF6A-4B53-B488-48312CBD4DFE Q33616671-CBA0DA1B-8180-4088-9B8D-DDBB414B68F5 Q33674324-69FA0870-37FE-42B5-8FFE-65D1FEEEC78D Q34034234-B9F7AD7A-C24C-4C87-A8CD-932220C22A66 Q34157687-FF32320D-80FC-476B-B1F2-4940CC3E7FE5 Q34324403-CA3E1295-A44D-4C2F-AC11-9A80200C236B Q34979975-A2244718-7502-4CF8-9385-AEA1F39B6A28 Q35146397-70EC867E-CD69-4E41-9276-B10DB0092CD3 Q35171241-30CE6B7A-D68E-4B96-8E48-B0F5267C10B2 Q35544839-72B59C07-7CC5-4DD6-88B1-FCC1CA2A14EF Q35690516-04944A74-686E-40A3-AC70-7015F390281A Q35903773-E9C5A256-5247-4A42-962A-A9E666008140 Q36048134-E5E4F03E-95FB-4285-A3F2-656E04C4EE1F Q36152206-7EC4F8AB-5693-46A1-AF74-AA8813D0864A Q36293950-AD2032D0-1274-48EF-A144-FDD8CF265F5E Q36485411-AA2B44AB-FAA7-4EED-A2F7-55E3EC376A8E Q36607562-1E609BE0-E266-456B-B160-EBCD8893AFEA Q36676559-2703DFDC-12DA-4D90-B7C9-F8587B4251D6 Q36745115-B38595A0-1A38-4986-9A99-C62E4E1A9E5B Q37000282-6515310C-868E-4831-99CC-239928261DCA Q37421645-9E5F97AE-235C-46B9-A3D7-7D0622409E65 Q37684600-7D013863-15DA-4659-B6B3-CE15331BF42B Q38202166-DB25CE42-CCFD-43E3-B358-458B30D2BD73 Q38308759-F218571A-85C6-4DF7-8493-45B9C6F438B0 Q38365443-0524F95D-A0FD-4678-B2D7-820257CC4529 Q38647501-6B03089A-4A80-464A-8D08-8F2A8DEA203A Q38686217-283F5C40-6515-4CA6-9FC6-790487F8A613 Q38715343-E6D5C07F-9713-4464-AD95-BCD456919DC6 Q38796261-0DDD3930-E1A0-4B32-BA59-398593949AD4 Q38884048-A03BAE4C-ECDF-4485-8AFD-8D711D4531DD Q38946242-90121F0C-8F33-41B2-976D-F4C68AC59E59 Q38970523-1DF157FB-19FB-41BC-9D7F-9DC6694D40AE Q41204585-BD82E646-CECC-41EE-87F8-FD12FD384C0D Q49517494-BDC8DE85-7263-47B0-AB21-7A3B4D04DBB2 Q49544302-965C9C32-EF71-4853-B587-132646211921 Q57029706-484BF534-1981-4468-8240-A8569B2A9DD0 Q57826206-D270E849-62CC-4D50-B25F-C4F64043D6D2 Q58587915-426F2D22-F4AC-48D6-B82D-3C049C8741DE

P2860

A quantitative atlas of histone modification signatures from human cancer cells

http://www.wikidata.org/entity/Q37008808

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A quantitative atlas of histone modification signatures from human cancer cells

@en

A quantitative atlas of histone modification signatures from human cancer cells.

@nl

type

label

A quantitative atlas of histone modification signatures from human cancer cells

@en

A quantitative atlas of histone modification signatures from human cancer cells.

@nl

prefLabel

A quantitative atlas of histone modification signatures from human cancer cells

@en

A quantitative atlas of histone modification signatures from human cancer cells.

@nl

P1433

Q37008808-83206B6E-EEC7-4027-8DDE-A922D1A54AC7

P1476

Q37008808-0A3FE1B6-E6C8-45EA-A27D-4A49C337442F

P2093

Q37008808-3245035F-0C5B-4166-BA49-DAD0C80AF1FE

Q37008808-5B2B442F-95F3-4765-BEEA-2038987F6915

Q37008808-67B96CF4-B37F-43C3-AE05-11FDC53E3826

Q37008808-702E76E5-4271-4EA7-913C-4FF332161ABE

Q37008808-7416621E-5CE0-4023-97A0-95C4EC131D17

Q37008808-7D784E96-CF0D-482C-8948-D57D715F10AC

Q37008808-D6CE49F7-62EE-414F-AB62-FF997474F8DE

Q37008808-D851CC6B-F4A9-4ABA-932B-5C2702812224

Q37008808-DFF966F7-52D8-44AF-8255-DF926742AC28

Q37008808-F1348F95-4396-4EBD-9910-4AE539136473

P2860

Q37008808-04FE4ECA-BB44-4D6C-9AB1-33D410B47ACE

Q37008808-0AC39377-FB8C-4AAB-9C83-2825541FDD80

Q37008808-0BB065C3-381F-423C-BEEF-A52424238E1D

Q37008808-0D2CA87C-644E-400A-AF3C-65598660B413

Q37008808-1677D3FF-A6AE-406F-B4E2-68496A40D5E6

Q37008808-20F39893-9B1D-492C-9111-2870D2FF5F0D

Q37008808-22778E28-6181-4F4A-AB8B-B272BDDA3802

Q37008808-2A7FEAF1-79DA-470E-B8B8-593AF9DE3D40

Q37008808-31DA8AB3-50A5-47D5-973C-4F977632FC82

Q37008808-337672F2-4D35-4477-AD51-A95501D16C46

P2888

Q37008808-7FB5C064-4EED-450C-A958-1354D073AE94

P304

Q37008808-5B946C52-36B4-40C6-B68B-6CC351C65DB0

P31

Q37008808-85C1553D-FCDF-439D-B994-14812A8AA29A

P356

Q37008808-4D767572-9174-4842-AF99-E9CD852DDE09

P433

Q37008808-5C38C5FD-B7A8-45FB-8E5A-CCEAFFDC54B1

P478

Q37008808-AFC6AE2E-2BD6-4860-882A-15A7DF01AD4A

P577

Q37008808-BBF34540-28A4-4D5F-96EA-90E9A92723EA

P5875

Q37008808-CD231723-9788-4D5F-95CF-BC0ADB19CD8B

P6179

Q37008808-FF8C8DB8-4E38-42C9-97AF-68B8C837C790

P698

Q37008808-DDAA5F50-2F43-4301-93BB-472C2BB24E65

P932

Q37008808-0F6888EF-C0D0-4311-8014-6131F2C45AC5

P356

P1433

Epigenetics & Chromatin

P1476

A quantitative atlas of histone modification signatures from human cancer cells

@en

P2093

Barbara Bryant

http://www.w3.org/2001/XMLSchema#string

Barry M Zee

http://www.w3.org/2001/XMLSchema#string

Benjamin A Garcia

http://www.w3.org/2001/XMLSchema#string

Eric Y Chan

http://www.w3.org/2001/XMLSchema#string

Gary Leroy

http://www.w3.org/2001/XMLSchema#string

Ian Z Flaniken

http://www.w3.org/2001/XMLSchema#string

M Andres Blanco

http://www.w3.org/2001/XMLSchema#string

Patrick Trojer

http://www.w3.org/2001/XMLSchema#string

Peter A Dimaggio

http://www.w3.org/2001/XMLSchema#string

Sherry Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Translating the Histone Code

Hallmarks of Cancer: The Next Generation

Regulation of chromatin structure by site-specific histone H3 methyltransferases

Selective inhibition of BET bromodomains

TRIM24 links a non-canonical histone signature to breast cancer

Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation

Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.

Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

P2888

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8935-6-20

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245536601

http://www.w3.org/2001/XMLSchema#string

P6179

1001636366

http://www.w3.org/2001/XMLSchema#string

P698

23826629

http://www.w3.org/2001/XMLSchema#string

P932

3710262

http://www.w3.org/2001/XMLSchema#string